Antipsoriatic Effect of a Topical Formulation for the Treatment of Psoriasis Vulgaris
Status:
Completed
Trial end date:
2013-07-01
Target enrollment:
Participant gender:
Summary
The current most important topical treatments for psoriasis are vitamin D3 analogues and/or
corticosteroids. The possibility of another effective treatment for psoriasis could be based
on the immunosuppressive efficacy of selective blockers of a lymphocyte potassium channel.
The aim of the clinical trial is to evaluate the safety, tolerability and anti-psoriatic
efficacy of topical SPS4251 formulations in comparison to placebo and to a marketed topical
Vitamin-D analogue ointment in a psoriasis plaque test.